Literature DB >> 16283477

All-cause mortality and mortality of myocardial infarction for 989 legally castrated men.

Finn Edler von Eyben1, Christian Graugaard, Michael Vaeth.   

Abstract

BACKGROUND: Male gender is an independent coronary risk factor.
METHOD: Long-term follow-up of 989 Danish men who underwent legal castration between 1929 and 1968.
RESULTS: The legally castrated men were unmarried and belonged to social class IV and V more often than were Danish men in general. During the follow-up until 2000, 835 of the 989 (85%) castrated men died, including 148 who died of myocardial infarction. In multiple Poisson regression analyses, the men had a standardized mortality rate (SMR) for all-cause mortality of 1.30 (95% CI: 1.26-1.36) and a SMR for mortality of myocardial infarction of 1.08 (95% CI: 1.04-1.16). Thus, the castrated men had a lower proportion of deaths of myocardial infarction (148/792, 18.7% (95% CI: 16.0-21.6%)) than was expected based on the mortality rates for the Danish male population (136/608, 22.4%). The castrated men had discordant changes for the SMR for all-cause mortality and mortality of myocardial infarction whereas subgroups of the Danish population previously has been found to have concordant changes for the two SMRs.
CONCLUSION: The castrated men had fewer deaths of myocardial infarction than expected, so men may not have increased risk of coronary heart disease from unphysiologically low levels of endogenous androgens.

Entities:  

Mesh:

Year:  2005        PMID: 16283477     DOI: 10.1007/s10654-005-2150-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Socioeconomic status and ischaemic heart disease mortality in middle-aged men: importance of the duration of follow-up. The Copenhagen Male Study.

Authors:  P Suadicani; H O Hein; F Gyntelberg
Journal:  Int J Epidemiol       Date:  2001-04       Impact factor: 7.196

2.  Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.

Authors:  M Pärssinen; U Kujala; E Vartiainen; S Sarna; T Seppälä
Journal:  Int J Sports Med       Date:  2000-04       Impact factor: 3.118

3.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

Authors:  S Sans; H Kesteloot; D Kromhout
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

4.  Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes.

Authors:  T Drivsholm; H Ibsen; M Schroll; M Davidsen; K Borch-Johnsen
Journal:  Diabet Med       Date:  2001-02       Impact factor: 4.359

5.  Is atherosclerotic cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox.

Authors:  Gerald B Phillips
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

6.  Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  BMJ       Date:  2001-09-08

7.  Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Authors:  C J Malkin; P J Pugh; P D Morris; K E Kerry; R D Jones; T H Jones; K S Channer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Intra-abdominal obesity and metabolic risk factors: a study of young adults.

Authors:  F E von Eyben; E Mouritsen; J Holm; P Montvilas; G Dimcevski; G Suciu; I Helleberg; L Kristensen; R von Eyben
Journal:  Int J Obes Relat Metab Disord       Date:  2003-08

9.  The sex differential in mortality from all causes and ischemic heart disease.

Authors:  D L Wingard; L Suarez; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

10.  Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population.

Authors:  J B Hamilton; G E Mestler
Journal:  J Gerontol       Date:  1969-10
View more
  5 in total

Review 1.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

Review 2.  Evolution of sexually dimorphic longevity in humans.

Authors:  David Gems
Journal:  Aging (Albany NY)       Date:  2014-02       Impact factor: 5.682

3.  Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

Authors:  Lin Xu; Guy Freeman; Benjamin J Cowling; C Mary Schooling
Journal:  BMC Med       Date:  2013-04-18       Impact factor: 8.775

Review 4.  The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials.

Authors:  C Mary Schooling; Shiu Lun Au Yeung; Guy Freeman; Benjamin J Cowling
Journal:  BMC Med       Date:  2013-02-28       Impact factor: 8.775

5.  Could androgens be relevant to partly explain why men have lower life expectancy than women?

Authors:  C Mary Schooling
Journal:  J Epidemiol Community Health       Date:  2015-12-09       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.